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commitment and A1C. Patients completed the Altarum Consumer
Engagement (ACE) measure. Multiple A1C values were extracted from medical
records for 273 military beneficiaries. Effects were analyzed with generalized
linear models. The ACE Commitment subscale was significantly inversely
related to A1C trends. Low-commitment patients were more likely to have a
high A1C. High-commitment patients were 16% more likely to have an A1C
<7.0%; this likelihood increased to 65% over time. The ACE Commitment
domain may be a useful clinical tool. Increasing patients’ commitment to
managing diabetes may improve their A1C over time.
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iabetes is a chronic disease
that affects 25.8 million
Americans, or about 8.3% of
the U.S. population (1). About 95%
of adults with diabetes are diagnosed
with type 2 diabetes, and incidence
rates for diabetes have been steadily
increasing since the mid‐1990s (1). In
addition, more is being asked of patients in health care interactions than
ever before. The move toward patient‐
centered medical homes is transforming primary care practices and driving
patients toward a more active role in
health care interactions (2).
Increasingly, patients must be
more engaged in managing health
information and making complex
health care decisions (3). Patient
engagement is key within the context
of a chronic care model (4). Although
being fully engaged in one’s health
care can be challenging, the benefits are numerous, yielding safer (5),
more effective (6), and less expensive
(7) health care. Additionally, patients
who actively participate in care decisions report higher satisfaction (5),
faster recovery from illness (8), and
improved quality of life. Finally,

care plans resulting from a shared
decision‐making process have been
shown to result in more effective use
of medication (9) and improved clinical outcomes (10,11).
There are several definitions of
what it means for a patient to be fully
engaged in health care decisions (12).
Patient engagement is often defined
within cognitive, emotional, or
behavioral components. In biomedical research, patient engagement is
distinct in terms of patient attitude;
behavioral health research defines
patient engagement as clinical alliance; and in nursing research, it is
delineated as emotional factors that
facilitate healthy behaviors. Public
health defines patient engagement as
consumer empowerment with a focus
on health policy (3). We choose to
define patient engagement as personal
value in health care, self-efficacy, and
use of skills and knowledge to create
healthy behaviors within a supportive
environment (3,4,13).
Although definitions abound,
there has been less work toward developing practical measures of patient
engagement. The Diabetes Empower-

295

F E AT U R E A R T I C L E

■ IN BRIEF This study examined the relationship between patient

F E AT U R E A R T I C L E

ment Scale has been described as a
measure for self-efficacy (14). Although Hibbard’s Patient Activation
Measure is widely used (15), it measures only a subset of the full range
of the concepts advanced by the Engagement Behavior Framework (16).
Tucked within the notion of
patient engagement is the specific
topic of patient commitment, which
has been an important topic of discussion for patients with chronic disease.
Patient commitment is delineated as a
personal investment and value toward
enacting health-related behaviors
(17). Regarding the physician-patient
relationship, patient commitment
has been cited as positively influencing medical adherence and healthy
behaviors (18). Beyond commitment
is the notion of patient empowerment
from health care providers to promote
a psychological state that determines
behavior and self-management. This
step involves the complexity of supporting patients with autonomy and
decision-making and enabling individuals with chronic disease to take
charge of their own health (19,20).
Although several scales have
captured aspects of patient commitment, in 2013, Altarum Institute,
a Michigan‐based nonprofit health
care research organization, validated
the Altarum Consumer Engagement
(ACE) Measure (21) with national
and employer respondents of varying
levels of health. However, it has not
been applied specifically with patients
who have chronic diseases such as
diabetes. Within the ACE Measure,

the Commitment domain focuses
on patient commitment to healthpromoting behaviors and has been
found to be related to both self-rated
patient health status and being at
least 10 lb overweight (21).
Objective

This study examined the relationship
between commitment as measured
by the ACE Commitment domain
and diabetes management. We hypothesized that higher levels of patient commitment would be associated with more successful diabetes
management.
Methods
Design

Wilford Hall Ambulatory Surgical
Center institutional review board
approval was obtained. The Diabetes
Center of Excellence (DCOE), which
is a U.S. Air Force diabetes specialty clinic, partnered with Altarum
Institute to collect and analyze the
data. Potential participants included
Department of Defense adult beneficiaries 18–70 years of age. In addition, only patients being treated at the
DCOE who were diagnosed with type
2 diabetes for >1 year were eligible.
A DCOE research coordinator
identified potentially eligible patients
before their scheduled appointment.
A red tag with information about the
study was placed in patients’ folders.
This red tag was a signal to providers
to briefly discuss the study with their
patients and invite them to participate. After patients checked out with

the front office receptionist, interested patients met with the research
coordinator to learn more about the
study.
After completing the informed
consent process, participants were
asked questions pertaining to demographics and given the ACE Measure.
The instrument was in English; therefore, it excluded participants who
could not speak or read English. The
next phase of the study included an
electronic chart review of the survey
respondents. Clinical information
was extracted, including retrospective A1C, BMI, and significant health
events such heart attacks, strokes,
hospitalizations for diabetic complication(s), and emergency room visits.
Measures

The survey included 21 items from
the validated ACE Measure (21),
which assessed patient engagement
in four domains: 1) Commitment,
2) Ownership, 3) Navigation, and
4) Informed Choice. Response
choices were as follows: 1 = strongly disagree; 2 = disagree; 3 = neither
agree nor disagree; 4 = agree; and 5 =
strongly agree. This study focused on
the Commitment domain (Table 1),
which has been associated with
health-related behaviors such as diet,
exercise, and medication adherence
(21).
Variables

The ACE Commitment domain
variables were scored as described
by Duke et al. (21) to create a 0–25
score. This score was then split into

TABLE 1. ACE Measure Commitment Domain
Patient Instructions: Please read each response. On a scale from 1 to 5, tell us if you agree with the statement.
Commitment
C1. I can stick with plans to exercise and eat a healthy diet.
C2. Even when life is stressful, I know I can continue to do the things that keep me healthy.
C3. When I work to improve my health, I succeed.
C4. I handle my health well.
C5. I take responsibility for managing my health.
C6. I take an active role in my own health care.
Response choices included 1 = strongly disagree; 2 = disagree; 3 = neither agree nor disagree; 4 = agree; and
5 = strongly agree.
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TABLE 2. Sample Characteristics by Sex

Sex
Mean age, years

Overall
(n = 273)

Female
(n = 114)

Male
(n = 159)

—

114 (41.8)

159 (58.2)

58.46

57.82

58.92

Race
196 (74.8)

83 (76.9)

113 (73.4)

African American

51 (19.5)

16 (14.8)

35 (22.7)

API

13 (5.0)

8 (7.4)

5 (3.2)

AIAN

2 (0.8)

1 (0.9)

1 (0.6)

Non-Hispanic

171 (62.6)

68 (59.6)

103 (64.8)

Hispanic

100 (36.6)

45 (39.5)

55 (34.6)

67 (24.8)

53 (46.9)

14 (8.9)

Caucasian

Ethnicity

Employment status
Employed

Analysis

Unemployed

38 (14.1)

30 (26.5)

8 (5.1)

Effects were analyzed both descriptively and with generalized linear
models using PROC GENMOD in
SAS (SAS Institute, Cary, N.C.) to
include demographic variables such
as patient age, sex, income, education, and self-reported health status.
The generalized linear model used a
multinomial outcome for three levels of A1C status: <7.0%, 7.0–8.9%,
and ≥9.0%. Regardless of whether
patients had an A1C value <7.0%
or ≥9.0%, the values were treated as
two binomial variables. Models across
time were analyzed as repeated measures with a generalized estimating
equation model, with z tests for individual predictors. Models comparing single time points, such as scores
within time 1 or time 3 only, used
maximum likelihood parameter estimates with Wald χ2 tests.

Retired military (employed)

79 (29.3)

10 (8.8)

66 (42.0)

Retired military (unemployed)

86 (31.9)

20 (17.7)

69 (43.9)

High school/GED

45 (16.5)

27 (23.7)

18 (11.3)

Some college

119 (43.6)

45 (39.5)

74 (46.5)

College graduate

57 (20.9)

20 (17.5)

37 (23.3)

Graduate degree

45 (16.5)

17 (14.9)

28 (17.6)

<$15,000

38 (13.9)

32 (28.1)

6 (3.8)

$15,000 to $34,999

40 (14.7)

20 (17.5)

20 (12.6)

$35,000 to $49,999

44 (16.1)

14 (12.3)

30 (18.9)

$50,000 to $64,999

38 (13.9)

13 (11.4)

25 (15.7)

$65,000 to $74,999

24 (8.8)

4 (3.5)

20 (12.6)

$75,000 to $99,999

33 (12.1)

9 (7.9)

24 (15.1)

≥$100,000

23 (8.4)

6 (5.3)

17 (10.7)

Declined to answer

33 (12.1)

16 (14.0)

17 (10.7)

Poor

18 (6.6)

6 (5.3)

12 (7.5)

Fair

64 (23.4)

26 (22.8)

38 (23.9)

Average

73 (26.7)

33 (28.9)

40 (25.2)

Good

107 (39.2)

44 (38.6)

63 (39.6)

11 (4.0)

5 (4.4)

6 (3.8)

Low

72 (26.2)

27 (23.7)

45 (28.3)

Moderate

141 (51.3)

61 (53.5)

80 (50.3)

High

60 (21.8)

26 (22.8)

34 (21.4)

Results

Descriptive results including demographics, ACE Commitment level,
and health outcomes are shown in
Table 2. The sample included 273
participants; 58.2% were male. The
overall mean age was 58.46 years,
with women (mean age 57.82 years)
being slightly younger than men
(mean age 58.92 years). Participants
were primarily Caucasian (74.8%) or
African American (19.5%); one-third
were Hispanic. Most participants
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Education level

Income category

Self-reported health status

Excellent
ACE Commitment level

Data are n (%) unless otherwise indicated. Totals may not be 100% because
of rounding and missing data. AIAN, American Indian/Alaskan Native; API,
Asian/Pacific Islander.
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three groups to indicate low, moderate, and high levels of commitment.
Low-commitment patients scored
<16 (26.2%), moderate-commitment
patients scored between 16 and 22
(51.3%), and high-commitment patients scored >22 on the 25-point
scale (21.8%).
A1C scores for up to three of the
most recent readings were categorized as well managed (A1C <7.0%),
not well managed (A1C 7.0–8.9%),
and poorly managed (A1C ≥9.0%).
The three readings occurred approximately 4 months apart on average
and were spread over an average of
8 months total (mean 237 days; SD
69 days).
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■ FIGURE 1. Percentage of people with diabetes with A1C <7% over time by commitment group.

were retired (61.2%), with 29.3% being employed after retirement from
the military. The majority of women
(58.7%) and men (50.9%) were employed. More men were college graduates (40.9%) than women (32.4%).
However, women were more likely to
live in a home with income >$50,000
(54.1%) than men (28.1%). Similar
rates of self-reported health status
were observed in men and women,
with overall self-reported health mostly fair (23.4%), average (26.7%), and
good (39.2%). Nearly half of the sample scored in the moderate-commitment category with about one-fourth
to one-third in each of the low- and
high-commitment groups.
When examining sample characteristics by commitment level,
individuals in the high-commitment
group were less likely to be obese
and more likely to rate their health
as “very good” or “excellent” compared to individuals in the low- or
moderate-commitment cohorts. The
proportion of patients within the
extreme A1C groups by commitment
level are shown in Figures 1 and 2.
DCOE patients with high commitment (37.0%) were more likely to
have A1C values <7.0% than patients
in the low-commitment (22.0%) or
moderate-commitment (22.0%)
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groups (Figure 1). The converse was
also apparent in that DCOE patients
with high commitment were less
likely to have an A1C ≥9.0% over
time than either low-commitment or
moderate-commitment patients
(Figure 2).
To analyze the effect of commitment group on A1C levels over
time while controlling for patient
characteristics, we conducted a
repeated-measures multinomial generalized linear model using PROC
GENMOD in SAS. Patient A1C
value (three levels: <7.0%, 7.0–8.9%,
and ≥9.0%) across three time measurements was the dependent variable
(Table 3). Patient ACE Commitment
level (low, moderate, or high) was
the primary independent variable.
Commitment was analyzed as a class
variable, with high commitment as
the reference class. Additional patient
characteristic variables included
sex, education, income, age, and
self-reported health. These patient
characteristics had no significant
relationship with A1C over time;
parameter estimates for the model are
shown in Table 4. The three readings
occurred ~4 months apart on average
and were spread over an average of 8
months total.

Model results found that patients
with high commitment were significantly more likely to be in a
healthier A1C group than lowcommitment (z = –3.0, P = 0.003)
or moderate-commitment (z = –2.5,
P = 0.013) patients. Additionally, the
magnitude of this difference in A1C
between high- and low-/moderatecommitment groups changed over
time, as indicated by two significant
interactions between low and high
commitment × time (z = 2.6, P = 0.01)
and moderate and high commitment × time (z = 2.6, P = 0.01).
To better understand the interaction effects in commitment over
time on A1C level, we conducted a
number of tests to contrast specific
effects, controlling for all demographics in the full model. These
effects show that over time, highcommitment patients were more
likely to keep their A1C value <7.0%
than low-commitment (z = 1.89,
P = 0.059) or moderate-commitment
(z = 2.08, P = 0.038) patients.
Likewise, high-commitment patients
were less likely to have an A1C
value ≥9.0% over time compared to
low-commitment patients (z = 2.74,
P = 0.006). This effect was also subject to an interaction where the size of
this gap increased over time (z = 1.92,

CLINICAL.DIABETESJOURNALS.ORG

WARDIAN ET AL.

F E AT U R E A R T I C L E

■ FIGURE 2. Percentage of people with diabetes with A1C ≥9% over time by commitment group.
TABLE 3. Sample Characteristics by Commitment Level
Overall
(n = 273)

Low
Commitment
(n = 72)

Moderate
Commitment
(n = 141)

High Commitment
(n = 60)

Third most recent A1C
<7.0%

43 (22.2)

11 (22.0)

20 (20.6)

11 (23.9)

7.0–8.9%

100 (51.5)

24 (48.0)

53 (54.6)

23 (48.9)

≥9.0%

51 (26.3)

15 (30.0)

24 (24.7)

12 (25.5)

<7.0%

64 (26.8)

18 (26.5)

31 (23.7)

20 (34.5)

7.0–8.9%

132 (48.6)

32 (47.1)

67 (51.1)

26 (44.8)

≥9.0%

61 (24.5)

18 (26.5)

33 (25.2)

12 (20.7)

<7.0%

69 (25.3)

16 (22.2)

31 (22.0)

22 (36.7)

7.0–8.9%

139 (50.9)

31 (43.1)

79 (56.0)

29 (48.3)

≥9.0%

65 (23.8)

25 (34.7)

31 (22.0)

9 (15.0)

197 (73.2)

54 (76.1)

106 (76.8)

37 (61.7)

Emergency department use

91 (33.3)

21 (29.2)

51 (36.2)

19 (31.7)

Admitted as inpatient

54 (19.8)

22 (30.6)

21 (14.9)

11 (18.3)

Second most recent A1C

Most recent A1C

Clinical obesity
BMI ≥30 kg/m2
Hospitalization

Self-rated health
Poor

18 (6.6)

11 (15.3)

6 (4.3)

1 (1.7)

Fair

64 (23.4)

20 (27.8)

35 (24.8)

9 (15.0)

Good

73 (26.7)

15 (20.8)

42 (29.8)

16 (26.7)

Very Good

107 (39.2)

25 (34.7)

53 (37.6)

29 (48.3)

11 (4.0)

1 (1.4)

5 (3.5)

5 (8.3)

Excellent
Data are n (%) unless otherwise indicated.
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TABLE 4. Generalized Estimating Equation Parameter Estimates
for Repeated-Measures Multinomial Generalized Linear Model
of Patient Characteristics and ACE Commitment Level on A1C
Over Time
Parameter

Estimate*

SE

z

P

Female

0.047

0.204

0.23

0.8175

Education

0.060

0.093

0.65

0.5188

Income

0.027

0.046

0.58

0.5628

Age

–0.014

0.012

–1.10

0.2728

Self-rated health

0.004

0.095

0.04

0.9697

Time

0.017

0.123

0.14

0.8893

Low commitment

–1.184

0.394

–3.00

0.0027

Moderate commitment

–0.822

0.330

–2.49

0.0128

High commitment

0.000

0.000

Ref.

Ref.

Time × low commitment

0.471

0.181

2.59

0.0095

Time × moderate commitment

0.392

0.153

2.56

0.0105

Time × high commitment

0.000

0.000

Ref.

Ref.

*Generalized estimating equation parameter estimate. Ref., reference
category.

P = 0.055); in other words, as time
went on, low-commitment patients
were increasingly likely to have a
high A1C compared to high-commitment patients. Additionally, highcommitment patients were significantly less likely to be at risk of high
A1C at time 3 than at time 1 (z =

2.09, P = 0.037). These results are
shown in Table 5.
Additional tests examined differences between commitment levels
at specific time points. At time 1,
all three commitment level groups
were similar in the proportion of
patients with A1C scores <7.0% and

≥9.0%. By time 3, significant differences emerged. High-commitment
patients were more likely to have an
A1C value <7.0% compared to lowcommitment (χ2 = 3.26, P = 0.071)
and moderate-commitment (χ2 =
4.42, P = 0.036) patients. Likewise,
at time 3, high-commitment
patients were less likely to have an
A1C of ≥9.0% than low-commitment patients (χ2 = 6.96, P = 0.008),
indicating that high-commitment
patients were more likely to have
healthier A1C at the final reading
(Table 6).
Collectively, these results show
that, although early measurements
of A1C showed similar outcomes
in diabetes management, over an
8-month period, outcomes diverged
widely by commitment groups. After
8 months, high-commitment patients
were more likely to keep their A1C
well managed and <7.0% compared
to low- and moderate-commitment
patients. Likewise, high-commitment
patients were less likely to have poorly
managed A1C values ≥9.0% compared to low-commitment patients.
This result suggests that the ACE
Commitment level may be predic-

TABLE 5. Tests of Specific Contrasts of Commitment Level and A1C Category Over Time
Comparison

Estimate*

SE

z

P

0.996

0.526

1.89

0.0585

Proportion with A1C <7.0%
Low vs. high commitment (main effect, all times)
Moderate vs. high commitment (main effect, all times)

0.981

0.472

2.08

0.0378

Low vs. high commitment (interaction over time)

–0.306

0.268

–1.14

0.2545

Moderate vs. high commitment (interaction over time)

–0.298

0.252

–1.18

0.2365

Within low commitment only (time 1 vs. time 3)

0.049

0.167

0.29

0.7682

Within moderate commitment only (time 1 vs. time 3)

0.037

0.128

0.29

0.7711

Within high commitment only (time 1 vs. time 3)

0.308

0.195

1.58

0.1132

Low vs. high commitment (main effect, all times)

–1.458

0.531

–2.74

0.0061

Proportion with A1C of ≥9.0%
Moderate vs. high commitment (main effect, all times)

–0.624

0.496

–1.26

0.2082

Low vs. high commitment (interaction over time)

0.462

0.240

1.92

0.0545

Moderate vs. high commitment (interaction over time)

0.302

0.221

1.37

0.1715

Within low commitment only (time 1 vs. time 3)

0.105

0.167

0.63

0.5288

Within moderate commitment only (time 1 vs. time 3)

–0.015

0.192

–0.36

0.7159

Within high commitment only (time 1 vs. time 3)

–0.382

0.183

–2.09

0.0369

*Generalized estimating equation parameter estimate.
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TABLE 6. Tests of A1C by Commitment Level at Specific Time Points
Estimate*

SE

Wald χ2

P

Time 1 (least recent), low vs. high commitment

0.189

0.520

0.13

0.7165

Time 1 (least recent), moderate vs. high commitment

0.208

0.448

0.21

0.6432

Time 3 (most recent), low vs. high commitment

0.749

0.415

3.26

0.0710

Time 3 (most recent), moderate vs. high commitment

0.742

0.353

4.42

0.0355

–0.163

0.495

0.11

0.7420

Comparison
Proportion with A1C <7.0%

Proportion with A1C of ≥9.0%
Time 1 (least recent), low vs. high commitment

0.230

0.441

0.27

0.6024

Time 3 (most recent), low vs. high commitment

–1.228

0.466

6.96

0.0083

Time 3 (most recent), moderate vs. high commitment

–0.485

0.431

1.26

0.2608

*Maximum likelihood parameter estimate.

tive of diabetes outcomes, specifically
blood glucose outcomes.
Discussion

This study demonstrates an associative relationship between patient engagement as measurement by ACE
Commitment and glycemic control.
Patients with high commitment were
more likely to improve their A1C
over time, whereas patients with low
or moderate commitment did not improve over time. It is not clear whether commitment levels lead directly to
better management of A1C, or if they
are both influenced by additional variables; the relationship is likely to be
complex. However, these findings are
consistent with research showing that
increased locus of control and selfefficacy have a positive effect on clinical outcomes (22).
The ACE Measure may be a useful tool in clinical encounters. Its
Commitment domain could help
identify patients who require additional support for self-management.
This scale could be used by medical assistants, nursing staff, primary
care physicians, and specialists
during initial, annual, or follow-up
appointments. If the clinic has limited resources, we suggest targeting
patients with elevated A1C values.
Potential interventions for improving
commitment include motivational
interviewing, medical health tech-

VOLUME 3 6, NUMBER 4, FALL 2018

nology, education, and clinician
self-management support (23–28).
This study focuses on the relationship between commitment and A1C.
Current literature suggests a number
of ways commitment may be fostered.
Diabetes Self-Management
Education

In current clinical practice, providers
may use the ACE Commitment domain to identify patients who would
benefit from additional diabetes
self-management education (DSME)
and support (22). A potential intervention could target strengthening a
patient’s locus of control and confidence through DSME and support
(29–31). Perceived barriers interfere
with patient self-efficacy and have
been associated with worse diabetes self-care (30). Certainly, DSME
has the potential to decrease selfperceived barriers, increase locus of
control, and improve self-efficacy
(22). Increasing self-efficacy with
use of DSME has increased self-care
behaviors and glycemic control in
patients with type 2 diabetes in past
studies (30,31).
Clinician-Patient Partnerships

Clinician-patient partnerships may be
an effective intervention to increase
patient commitment (32). These
partnership strategies have included
clinicians partnering with patients
with use of shared decision-making
in medical management (33). Key

players in clinician-patient partnerships include specialists, primary
care providers, diabetes educators,
and nursing staff (34). Both knowledge of patients and support of their
autonomy are consistent within these
partnerships, therefore conveying a
respect and spirit of collaboration
(18). Clinician partnerships have
been noted to use a strategy of intentionally conveying caring and empathy to improve disease self-management (26). Clinician partnerships
may also involve enabling patients
to contribute to their own electronic
medical records or to have full access
to their electronic medical record
(35). Personalized goal-setting, identifying steps in achieving set goals,
and promoting ownership of their
diabetes management have been successful strategies (26,36). Thus, a clinician could identify at-risk patients
with low commitment through the
ACE Commitment scale and develop multidisciplinary appointments
to promote a clinician-patient partnership model aimed at improving
self-management through increasing
commitment.
Online Communication

Technology within health care has
enhanced communication, education, and self-management (35,37).
A secure online communication tool
could share information regarding
patients’ personal health, diet and
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exercise, and appointment reminders
to promote self-management among
vulnerable patients identified with
low commitment (38).
For example, in one study, patients
had online access to their clinical
notes through OpenNotes, which
increased management and confidence. Qualitative feedback suggested
that patients who used OpenNotes
felt a high level of partnership and
engagement (35). This tool also facilitates bidirectional communication
and continuing education. Other electronic tools have included registries
such as the Swedish Rheumatology
Quality Registry. This registry is
described as a platform for sharing
information electronically between
patients and health care providers,
providing patient education, and promoting discussion of personal goals
and research (39).
Motivational Interviewing

Motivational interviewing could be
used as an effective tool for increasing
patient commitment. Motivational
interviewing interventions have
been demonstrated to improve selfmanagement skills and glycemic management (40,41). In clinical practice,
the commitment questions could
explore barriers or life challenges,
confidence, and values. Individual
commitment questions could assist
in deciding what clinical support
strategies to explore. For example,
using statement C2, “Even when life
is stressful, I know I can continue to
do the things that keep me healthy,”
may trigger providers to explore life
stressors if the Commitment domain
score is low. Services provided may
include support groups, stress management techniques, or psychology or
psychiatry services. Motivational interviewing techniques have the potential to complement clinician-patient
partnership strategies, technology,
and self-management education.

domain scores are only known at one
time point close to the final A1C
reading. It is unclear what patients’
Commitment domain scores would
have been at the first A1C reading or
how commitment may have changed
over time. It is also unknown whether the relationship between commitment and A1C is causal or only correlational. We suggest the literature
on self-efficacy and locus of control
makes a case for commitment influencing health outcomes (42).
Moreover, patients in the study were
all Department of Defense beneficiaries receiving care in the DCOE,
a military diabetes specialty clinic;
thus, results may not be generalizable
to a civilian population or to primary
care patients.
Future Research

Additional research to replicate and
extend our findings is needed. Future
studies could include longitudinal
measurement of commitment and
how commitment relates to other
chronic health conditions, including obesity, prediabetes, hypertension, chronic obstructive pulmonary
disease, and chronic heart failure.
Furthermore, research studies are
needed to translate the commitment
scale into clinical practice using specific interventions, including motivational interviewing, use of electronic
communication, and clinician partnership models.
In conclusion, type 2 diabetes
affects millions of Americans and
inundates the U.S. health care system (1). Patients are asked to be more
involved in diabetes management,
despite limited resources (2,3). Use
of the ACE Measure, specifically the
Commitment domain, may identify
likelihood of successfully managing
A1C in diabetes patients, as well as
identify patients who need additional
support and clinic resources.
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